Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-30.89%
↓ 134% below average
Average (7y)
90.82%
Historical baseline
Range
High:425.95%
Low:-39.39%
Volatility
512.4%
High variability
| Period | Value |
|---|---|
| 2024 | -30.89% |
| 2023 | -39.39% |
| 2022 | 25.33% |
| 2021 | 26.23% |
| 2020 | 215.72% |
| 2019 | 103.58% |
| 2018 | 425.95% |
| 2017 | 0.00% |